Atossa Therapeutics
ATOS
#9338
Rank
HK$0.71 B
Marketcap
HK$5.56
Share price
-13.37%
Change (1 day)
-33.18%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: HK$0.71 Billion

As of December 2025 Atossa Therapeutics has a market cap of HK$0.71 Billion. This makes Atossa Therapeutics the world's 9338th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$0.71 B-25.06%
2024HK$0.95 B11.26%
2023HK$0.86 B64.71%
2022HK$0.52 B-66.9%
2021HK$1.57 B351.14%
2020HK$0.35 B213.65%
2019HK$0.11 B139.08%
2018HK$46.69 M-28.58%
2017HK$65.38 M57.88%
2016HK$41.41 M-48.87%
2015HK$80.99 M-70.27%
2014HK$0.27 B-18.46%
2013HK$0.33 B-14.44%
2012HK$0.39 B

End of Day market cap according to different sources

On Dec 15th, 2025 the market cap of Atossa Therapeutics was reported to be:

HK$0.71 Billion
by Nasdaq info icon info icon
HK$0.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.013 T 558,831.25%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$170.21 B 23,603.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$160.14 B 22,200.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
HK$0.28 B-60.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
HK$21.96 B 2,958.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
HK$11.99 B 1,570.63%๐Ÿ‡บ๐Ÿ‡ธ USA